GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Iconovo AB (OSTO:ICO) » Definitions » EV-to-Revenue

Iconovo AB (OSTO:ICO) EV-to-Revenue : 17.68 (As of Jul. 04, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Iconovo AB EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Iconovo AB's enterprise value is kr30.10 Mil. Iconovo AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was kr1.70 Mil. Therefore, Iconovo AB's EV-to-Revenue for today is 17.68.

The historical rank and industry rank for Iconovo AB's EV-to-Revenue or its related term are showing as below:

OSTO:ICO' s EV-to-Revenue Range Over the Past 10 Years
Min: 7.13   Med: 21.53   Max: 57.26
Current: 17.69

During the past 9 years, the highest EV-to-Revenue of Iconovo AB was 57.26. The lowest was 7.13. And the median was 21.53.

OSTO:ICO's EV-to-Revenue is ranked worse than
89.36% of 818 companies
in the Medical Devices & Instruments industry
Industry Median: 3.175 vs OSTO:ICO: 17.69

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-07-04), Iconovo AB's stock price is kr2.00. Iconovo AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was kr0.08. Therefore, Iconovo AB's PS Ratio for today is 24.10.


Iconovo AB EV-to-Revenue Historical Data

The historical data trend for Iconovo AB's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Iconovo AB EV-to-Revenue Chart

Iconovo AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only 18.56 38.04 25.13 17.66 24.23

Iconovo AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.25 20.97 26.61 24.23 29.27

Competitive Comparison of Iconovo AB's EV-to-Revenue

For the Medical Devices subindustry, Iconovo AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Iconovo AB's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Iconovo AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Iconovo AB's EV-to-Revenue falls into.


;
;

Iconovo AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Iconovo AB's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=30.095/1.702
=17.68

Iconovo AB's current Enterprise Value is kr30.10 Mil.
Iconovo AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1.70 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Iconovo AB  (OSTO:ICO) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Iconovo AB's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=2.00/0.083
=24.10

Iconovo AB's share price for today is kr2.00.
Iconovo AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.08.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Iconovo AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Iconovo AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Iconovo AB Business Description

Traded in Other Exchanges
N/A
Address
Ideongatan 3 A-B, Delta 6, Lund, SWE, SE-223 62
Iconovo AB develops new inhaled medicinal products in collaboration with international pharmaceutical companies. The company provides several types of patent-protected inhalers that can generate significant commercial opportunities in the development of novel pharmaceuticals and vaccines and at patent expirations for established pharmaceuticals. The project is a generic version of the asthma and COPD product Symbicort.

Iconovo AB Headlines

No Headlines